scholarly journals Neck circumference in adolescents and cardiometabolic risk: A sistematic review

2018 ◽  
Vol 64 (1) ◽  
pp. 54-62 ◽  
Author(s):  
Aisha Aguiar Morais ◽  
Urjel Aguiar Bouissou Morais ◽  
Maria Marta Sarquis Soares ◽  
Márcia Christina Caetano Romano ◽  
Joel Alves Lamounier

Summary Objective: To critically analyze articles on the relation between neck circumference (NC) in adolescents and: body mass index, fat distribution, metabolic syndrome and its individual components, and cardiovascular risk. Method: Systematic review undertaken by two independent researchers using the Pubmed/Medline, Lilacs/Medline, Scielo and Cochrane databases in English, Spanish and Portuguese in the period comprising the past 5 years. Results: Eighteen (18) articles were selected. The articles show an association between NC in adolescents and body fat (BMI), central fat distribution (WC), metabolic syndrome and several of its individual components, and cardiovascular risk. Some values are proposed for NC cutoff points as a diagnostic tool for nutritional status, high blood pressure and pre-hypertension, cardiovascular risk, insulin resistance and metabolic syndrome. We identified a percentile curve constructed for Brazilian adolescents. Conclusion: There is a shortage of studies with representative samples, variety at the NC measurement sites, and the age of the participants, which makes it difficult to establish definitive landmarks.

2009 ◽  
Vol 150 (18) ◽  
pp. 821-829 ◽  
Author(s):  
Judit Nádas ◽  
György Jermendy

Although the clustering of cardiovascular risk factors is unquestionable, the clinical significance of the metabolic syndrome as a distinct entity has been debated in the past years. Recently, the term ‘metabolic syndrome’ has been replaced by ‘global cardiometabolic risk’ which implies cardiovascular risk factors beyond the metabolic syndrome. The metabolic syndrome can be frequently detected among people in western and developing countries affecting 25-30% of adult population, and its prevalence rate is increasing. Prospective studies show that the metabolic syndrome is a significant predictor of incident diabetes but has a weaker association with cardiovascular morbidity and mortality. At the same time the metabolic syndrome is inferior to established predicting models for either type 2 diabetes or cardiovascular disease.The underlying pathomechanism of the metabolic syndrome is still poorly understood. The role of insulin resistance – although not as a single factor – is still considered as a key component. In the last decade the importance of abdominal obesity has received increased attention but some studies, mainly in the Asian population, showed that central obesity is not an essential component of the syndrome. Regardless of the theoretical debates the practical implications are indisputable. The frequent clustering of hypertension, dyslipidaemia and glucose intolerance, that often accompanies central obesity, can not be ignored. Following the detection of one risk factor, the presence of other, traditional and non-traditional factors should be searched for, as the beneficial effect of intensive, target oriented, continuous treatment of metabolic and cardiovascular risk factors has been proven in both the short and long term.


2018 ◽  
Vol 10 (1) ◽  
Author(s):  
Asal Ataie-Jafari ◽  
Nazli Namazi ◽  
Shirin Djalalinia ◽  
Pouria Chaghamirzayi ◽  
Mohammad Esmaeili Abdar ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Dolly Sud ◽  
Eileen Laughton ◽  
Robyn McAskill ◽  
Eleanor Bradley ◽  
Ian Maidment

Abstract Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that there has not been a review of published studies on the role of pharmacy in relation to cardiometabolic risk, metabolic syndrome and related diseases (e.g. type 2 diabetes) in individuals with severe mental illness. Methods A mixed-methods systematic review was performed. Eleven databases were searched using a comprehensive search strategy to identify English-language studies where pharmacy was involved in an intervention for cardiometabolic risk, metabolic syndrome or related diseases in severe mental illness in any study setting from any country of origin. First, a mapping review was conducted. Then, implementation strategies used to implement the study intervention were classified using the Cochrane Effective Practice and Organisation of Care Taxonomy. Impact of the study intervention on the process (e.g. rate of diagnosis of metabolic syndrome) and clinical (e.g. diabetic control) outcomes were analysed where possible (statistical tests of significance obtained for quantitative outcome parameters reported). Quality assessment was undertaken using a modified Mixed Methods Appraisal Tool. Results A total of 33 studies were identified. Studies were heterogeneous for all characteristics. A total of 20 studies reported quantitative outcome data that allowed for detailed analysis of the impact of the study intervention. The relationship between the total number of implementation strategies used and impact on outcomes measured is unclear. Inclusion of face-to-face interaction in implementation of interventions appears to be important in having a statistically significantly positive impact on measured outcomes even when used on its own. Few studies included pharmacy staff in community or general practitioner practices (n = 2), clinical outcomes, follow up of individuals after implementation of interventions (n = 3). No studies included synthesis of qualitative data. Conclusions Our findings indicate that implementation strategies involving face-to-face interaction of pharmacists with other members of the multidisciplinary team can improve process outcomes when used as the sole strategy. Further work is needed on clinical outcomes (e.g. cardiovascular risk reduction), role of community pharmacy and qualitative studies. Systematic review registration PROSPERO CRD42018086411


2016 ◽  
Vol 33 (2) ◽  
Author(s):  
Raúl Aguilera Eguía

Recibimos su comentario sobre el artículo “High-intensity interval exercise therapy to reduce cardiovascular risk factors in people with the metabolic syndrome; systematic review with meta-analysis”. Queremos aclarar que el propósito del forest plotcorrespondiente al estudio individual era plasmar su resultado mediante un estimador puntual y no global. Para ambos casos su resultado no se ve alterado, debido a que considera un solo estudio.


2016 ◽  
Vol 33 (2) ◽  
Author(s):  
Raúl Aguilera Eguía

Recibimos su comentario sobre el artículo “High-intensity interval exercise therapy to reduce cardiovascular risk factors in people with the metabolic syndrome; systematic review with meta analysis”


2019 ◽  
Vol 5 (1) ◽  
pp. e000544 ◽  
Author(s):  
Graham Burne ◽  
Michael Mansfield ◽  
Jamie E Gaida ◽  
Jeremy S Lewis

ObjectivesRotator cuff-related shoulder pain (RCRSP) is a common upper limb complaint. It has been suggested that this condition is more common among people with cardiometabolic risk factors. This systematic review has synthesised evidence from case–control, cross-sectional and cohort studies on the association between metabolic syndrome (MetS) and RCRSP.Design and data sourcesFive medical databases (MEDLINE, EMBASE, SCOPUS, CINAHL and AMED) and reference checking methods were used to identify all relevant English articles that considered MetS and RCRSP. Studies were appraised using the Newcastle-Ottawa Scale (NOS). Two reviewers performed critical appraisal and data extraction. Narrative synthesis was performed via content analysis of statistically significant associations.ResultsThree cross-sectional, two case–control and one cohort study met the inclusion criteria, providing a total of 1187 individuals with RCRSP. Heterogeneity in methodology and RCRSP or MetS definition precluded a meaningful meta-analysis. Four of the included studies identified associations between the prevalence of MetS and RCRSP. Studies consistently identified independent cardiometabolic risk factors associated with RCRSP. All studies were level III evidence.Summary and conclusionThe low-moderate quality evidence included in this review suggests an association between MetS and RCRSP. Most studies demonstrated moderate quality on appraisal. The direction of association and cardiometabolic factors influencing should be investigated by longitudinal and treatment studies. These preliminary conclusions and clinical utility should be treated with caution due to limitations of the evidence base.


2013 ◽  
Vol 62 (3) ◽  
pp. 183-188 ◽  
Author(s):  
Karina Bezerra dos Santos Magalhães ◽  
Marcelo Moreira Magalhães ◽  
Erik Trovão Diniz ◽  
Cynthia Salgado Lucena ◽  
Luiz Griz ◽  
...  

2011 ◽  
pp. P2-563-P2-563
Author(s):  
Karina Magalhaes ◽  
Marcelo Magalhaes ◽  
Erik Diniz ◽  
Cynthia Lucena ◽  
Francisco Bandeira

Sign in / Sign up

Export Citation Format

Share Document